.
Phytoestrogens may be excreted in amounts hormonally comparable to the endogenous steroidal estrogens (1) . The intake of dietary estrogens is significantly higher in countries where the incidence of breast and prostate cancers is low, suggesting that they may act as chemopreventive agents (1) . The chemopreventive effect of dietary soy which is rich in phytoestrogens has recently been demonstrated on the development of estrogen-dependent mammary tumors (dimethylbenzanthraceneand nitrosomethylurea-induced mammary tumors in rats) (2) . These compounds may also account for the soy-effect seen as a delayed development of dysplastic changes in the prostate of neonatally estrogenized mice (3) .
Dietary estrogens are believed to exert their estrogenic or antiestrogenic (chemopreventive) action in estrogen responsive cells by interacting with the specific intracellular estrogen receptor (ER). In agreement with this, the compounds (coumestrol, genistein, and zearalenone) which are the most active biologically (e.g., enhance the proliferation of estrogen-responsive tumor cells), also have high binding affinities for ER (4) and have been shown to exert estrogenic activity in vitro (5 (16 wells) .
For T-47D cell proliferation experiments, we used phenol red-free DMEM with 10% dextran charcoal stripped FBS, insulin (7.5 pg/ml) and antibiotics as above. The stock cultures were harvested by trypsinization, resuspended with medium, and seeded on culture dishes (3 cm diameter). Cells were allowed to attach overnight, the media was changed, and the test compounds were added as above. The medium plus test compounds was changed every other day. At day 7, cells were counted in a Coulter counter.
Measurement of 17fi-Hydroxysteroid Oxidoreductase Activity
The capability of dietary estrogens to inhibit the estrogen-specific 17l3-hydroxysteroid oxidoreductase type I (E.C. 1.1.1.62) was tested by using the enzyme purified from human placenta (12) . An aliquot of the purified enzyme in 15 mM phosphate buffer, pH 7.4 with 2 mM DTT, 1 mM EDTA, 1 mM PMSF, and 10% glycerol was preincubated with the NADPH-generating system (50 pl 4 mM NADP, 50 pl glucose-6-phosphate, 50 pl glucose-6-phosphate dehydrogenase, 50 U/ml) in a final volume of 250 (16) . Relative velocities were calculated for each compound.
The type of enzyme inhibition was determined with a graphical method according to Dixon (17) . The reaction velocities were determined with a series inhibitor concentrations (1.2 nM to 0.12 pM) and with two substrate concentrations (0.24 and 0.72 pM). Straight lines were obtained on plotting 1/v versus i. The point of intersection of the two lines gave -KG.
The 17f-oxidoreductase activity of the MCF-7 cells was assessed by determining the ability of intact monolayers to convert added 3H-estrone to 3H-estradiol (13, 18 The estrogen-responsive reporter vector, ERET8 1CAT, and the pRSV vector containing the mouse ER cDNA (without the neomycin resistance cassette) was constructed as previously described (19) . The HeLa cells were cotransfected with these two vectors, +ER, or with only the ERET81 CAT reporter vector, -ER, to test the ER-mediated estrogenic activity of the phytoestrogens. The HeLa cells were grown in phenol red-free DMEM/F12 medium (Sigma) supplemented with 5% FBS and penicillin-streptomycin. Cells were harvested by trypsinzation and mixed with the ERET81CAT DNA, 70 pg/ml, and the pRSV-ER DNA, 10 pg/ml, or ERET81CAT only, 80 pg/ml. The cells were electroporated at 960 pFD, 0.4 kV in 0.8 ml of cells. Cells were then pooled and plated on fibronectin treated plates in DMEM/F12 plus insulin-transferrin-sodium selenite (Sigma). Four hours after transfection, the serum-free medium was replaced and 1 nM 17g-estradiol (E2) or varying concentrations of the dietary estro-gens were added as indicated. For incubation with the estrogen antagonist ICI 164,384 (ICI), the cells were pretreated for 1 hr with 100 nM ICI before co-incubating with the other hormones (20 Figure 2 show that coumestrol, genistein, biochanin A, zearalenone, and zeranol all significantly enhanced the proliferation of MCF-7 cells. The response was dose dependent in each case, and no inhibition was seen at the concentrations of 1 pM or less.
Coumestrol, zearalenone, and zeranol were potent at 10 pM while higher concentrations (more than 1 nM) were needed to show a significant estrogenic activity by genistein or biochanin A. For comparison with the dietary estrogen responses, the dose dependency of MCF-7 cell proliferation on 17B-estradiol and estrone is shown in Figure  3 . The stimulation became significant at 10 pM concentration and reached its maximum at 1 nM concentration of 17f1-estradiol. Considerably higher concentrations of estrone were needed to get a significant stimulation.
MCF-7 cell proliferation was analyzed for these same compounds in the presence (5) (13) . The capability of dietary estrogens to inhibit the estrogen-specific 17f;-hydroxysteroid oxidoreductase type I (E.C. 1.1.1.62) was tested by using the enzyme purified from human placenta. At a concentration of 12 nM, coumestrol significandy inhibited the enzyme, while considerably higher concentrations were needed to show inhibition with genistein (Table  1) . Zearalenone was inactive at the concentration of 1.2 1iM. The kinetic studies of the inhibition showed that the inhibition of the enzyme by coumestrol was competitive with N 9 nM. The effects of dietary estrogens on the oxidoreductase activity of MCF-7 cells which do not contain the placental form of the 17g-estradiol oxidoreductase (23), was assessed by determining the conversion of 3H-estr~one (2 nM) to H-estradiol during the 37 C incubation for 4 to 24 hr. The reduction of 3H-estrone was linear up to 8 hr after the addition of the substrate (Fig.  7) . Thereafter, the rate of reduction resulting in the formation of 3H-estradiol decreased and the ratio of estradiol to estrone changed little. Neither coumestrol nor genistein had a significant effect on the conversion of 3H-estrone and 3H-estradiol in MCF-7 cell cultures at the concentration of 1.2 pM (Fig. 7) . Zearalenone inhibited the reduction of 3H-estrone at 4 to 8 hr after the start of 3H-estrone addition (Fig. 7) . At 24 hr, the 3H-estradiol accumulation had reached the control level, i.e., the level found in cells cultured without phytoestrogens. In contrast to the findings in MCF-7 cells, coumestrol and genistein both inhibited the reduction of estrone to 17f3-estradiol in T-47D breast cancer cells which contain a similar form of the enzyme as found in the human placenta (Fig. 8) . Zearalenone had no effect on the conversion at any tested concentration.
To determine if inhibition of estrone conversion to 17f3-estradiol by coumestrol and genistein in T-47D cells could effect an estrogen-induced physiological response, cell proliferation of the ER-positive breast cancer cells was analyzed. The effects of the phytoestrogens coumestrol and genistein, alone or cotreatments with the estrogen agonist estrone, on the proliferation of T-47D cells are shown in Figure  9 . Both coumestrol and genistein stimulated the proliferation of the T-47D cells at 
